Advertisements



We are Sorry, This Page doesn't Exist


Morgan Stanley: DEA Likely To Reclassify GW Pharma"s Cannabinoid Therapy For US Launch

By Sunday night, the U.S. Drug Enforcement Administration is expected to reclassify GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)’s Epidiolex to allow medicinal use. This could open the therapy to a new and promising market. read more.....»»

Category: blogSource: benzingaSep 19th, 2018

A new report says pharma companies increased drug prices by nearly double during shortages — and it highlights the biggest debate in healthcare today

Unsplash/Freestocks.org Drug shortages are a constant worry for the US healthcare system.  Researchers looked at prices of drugs under shortage from 2015 to 2016 and found that manufacturers inc.....»»

Category: topSource: businessinsiderSep 18th, 2018

Apple announces iPhone XS, iPhone XS Max, less expensive iPhone XR in phone line revamp

At long last, Apple's new iPhones are official. As expected the company introduced two new iPhones: The iPhone XS, super-sized .....»»

Category: topSource: usatodaySep 12th, 2018

Silicon Valley"s ultra wealthy are reportedly buying up $8 million doomsday bunkers in New Zealand

Gene Page/AMC Super rich Silicon Valley moguls are buying up millions of dollars' worth of doomsday bunkers and installing them in New Zealand, Bloomberg reports. The most expensive cost $8 million and is and buried 11 .....»»

Category: topSource: businessinsiderSep 6th, 2018

Why Shares of Zuora Inc. Tumbled Today

A solid quarter wasn't enough to keep the super-expensive SaaS stock afloat......»»

Category: topSource: foxnewsAug 31st, 2018

UK rejects Gilead"s CAR-T cancer cell therapy as too expensive, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 28th, 2018

Oklahoma is implementing a new program that only pays big pharma full price if their drugs work

AP Under the conditions of a new Medicaid program in Oklahoma, the state will only pay drugmakers the full agreed-upon price of the drug if it works as advertised.  Oklahoma's plan is part of the Trump admin.....»»

Category: topSource: businessinsiderAug 20th, 2018

Inside the super-expensive condos in S.F. — one just sold for $15 million

The high rise officially opened Thursday for its sole commercial tenant, Facebook, and future owners of the 55 condominiums......»»

Category: topSource: moneycentralAug 9th, 2018

Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2018

Significant progress with RPL554 as potential treatment for COPD and CF Recently initiated important Phase 2 trial as add-on to dual bronchodilator therapy for COPD maintenance treatm.....»»

Category: earningsSource: benzingaAug 7th, 2018

2018 NFL Ticket Summary: Patriots Are Tops + Titans Have Biggest Increase

Most Expensive Prices For 2018: Despite losing the Super Bowl to the Eagles, the Patriots lead the league in NFL prices for the second season in a row. The Super Bowl Champion Eagles rank 3rd on the........»»

Category: blogSource: 247wallstAug 6th, 2018

How China Is Evolving From Copycat Medicines Into a Producer of Complex Drugs

Johnson & Johnson was impressed enough by Nanjing Legend Biotechnology’s work on an experimental gene therapy that it paid $350 million for the global rights to the cancer treatment......»»

Category: smallbizSource: wsjAug 5th, 2018

Here"s how 3 millennials cope with living in super expensive US cities

Comedy Central Katherine Lavacca doesn't have any savings and will have to start paying off student loans this summer. The 24-year-old journa.....»»

Category: topSource: businessinsiderAug 3rd, 2018

Roche (RHHBY) 1H18 Revenues Up Y/Y on Solid New Drug Sales

Roche's (RHHBY) performance in the first half is buoyed by solid strength in new drugs like Ocrevus. The increase in guidance is impressive as well. Swiss pharma .....»»

Category: worldSource: nytJul 27th, 2018

GlaxoSmithKline is acquiring $300 Million stake in 23andMe

GlaxoSmithKline has made a $300 million investment in DNA testing company 23andMe. The four-year deal aims to find faster and less expensive drugs and treatment options.  &#.....»»

Category: topSource: usatodayJul 25th, 2018

Johnson & Johnson profit beat fueled by strength in pharma business

Johnson & Johnson topped analysts' estimates for quarterly profit and revenue on Tuesday, as strong demand for cancer drugs Zytiga and Darzalex more than made up for declining sales of blockbuster treatment Remicade......»»

Category: topSource: reutersJul 17th, 2018

Johnson & Johnson quarterly profit beats on higher pharma unit sales

Johnson & Johnson on Tuesday topped analysts' estimates for quarterly profit and revenue, driven by higher sales of rare-disease treatments from its acquisition of Actelion and cancer drugs Zytiga and Darzalex......»»

Category: topSource: reutersJul 17th, 2018

More and more health care bills are over $1 million—and expensive drugs are playing a major role

The number of patients whose medical care cost at least a million dollars over the course of a year rose by nearly 90% between 2014 and 2017, according to a new report conducted by Sun Life......»»

Category: topSource: marketwatchJul 16th, 2018

Million-dollar health bills spike as drugs get more expensive

The number of patients whose medical care cost at least a million dollars over the course of a year rose by nearly 90% between 2014 and 2017, according to a new report conducted by Sun Life......»»

Category: topSource: moneycentralJul 16th, 2018

Million-dollar health bills spike as drugs get more expensive

The number of patients whose medical care cost at least a million dollars over the course of a year rose by nearly 90% between 2014 and 2017, according to a new report conducted by Sun Life......»»

Category: topSource: moneycentralJul 16th, 2018

Million-dollar health bills have spiked, and expensive drugs are playing a major role

The number of patients whose medical care cost at least a million dollars over the course of a year rose by nearly 90% between 2014 and 2017, according to a new report conducted by Sun Life......»»

Category: topSource: marketwatchJul 16th, 2018